Research progress on immune-checkpoint inhibitor-induced hepatotoxicity / 中华老年医学杂志
Chinese Journal of Geriatrics
;
(12): 619-623, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-933134
ABSTRACT
Immune checkpoint inhibitors(ICIs)treatment significantly prolonged the survival period of patients with lung cancer, liver cancer, and malignant melanoma and other solid malignant tumors and improved the quality of life.But at the same time a variety of immune-related adverse reactions(irAEs)appeared.The incidence of immune-mediated liver injury(IMH)caused by ICIs is increasing but the severity is different.To diagnose IMH earlier and perform individualized diagnosis and treatment, it is necessary to have a reasonable application of drug treatment.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Geriatrics
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS